检索结果筛选:

全文
出版年度
学科主题
作者
来源出版物
出版社
收录数据库
语种
国别/地区

文章检索列表

13 条结果, 检索条件:( ( *(AU:("Christian Scheerans")) ) )

排序: 导出:
[期刊论文]

Proposal for a standardised identification of the mono‐exponential terminal phase for orally administered drugs

作者:Christian Scheerans ;Hartmut Derendorf ;Charlotte Kloft

来源:Biopharmaceutics And Drug Disposition. 2008 ;29(3):145-157.doi:10.1002/bdd.596

出版社:John Wiley & Sons, Ltd.

全文购买

[期刊论文]

Proposal for defining the relevance of drug accumulation derived from single dose study data for modified release dosage forms

作者:Christian Scheerans ;Roland Heinig ;Wolfgang Mueck

来源:Biopharmaceutics And Drug Disposition. 2015 ;36(2):93-103.doi:10.1002/bdd.1923

出版社:John Wiley & Sons, Ltd.

全文购买

[期刊论文]

Concentration–response studies and modelling of the pharmacodynamics of linezolid: Staphylococcus aureus versus Enterococcus faecium

作者:Christian Scheerans ;Sebastian G. Wicha ;Julia Michael

来源:International Journal of Antimicrobial Agents. 2015 ;45(1):54-60.doi:10.1016/j.ijantimicag.2014.07.028

出版社:Elsevier BV

全文购买

[期刊论文]

Compliance assessment of ambulatory Alzheimer patients to aid therapeutic decisions by healthcare professionals

作者:Oliver Schwalbe ;Christian Scheerans ;Ines Freiberg

来源:BMC Health Services Research. 2010 ;10(1):232.doi:10.1186/1472-6963-10-232

出版社:BioMed Central

开放获取

[期刊论文]

Safety, Pharmacodynamics, and Pharmacokinetics of P2X3 Receptor Antagonist Eliapixant (BAY 1817080) in Healthy Subjects: Double-Blind Randomized Study

作者:Christian Friedrich ;Klaus Francke ;Isabella Gashaw

来源:Clinical Pharmacokinetics. 2022 ;61(8):1143-1156.doi:10.1007/s40262-022-01126-1

出版社:Springer Nature

全文购买

[期刊论文]

Assessment of the Effects of Renal Impairment on the Pharmacokinetics of the Soluble Guanylate Cyclase Activator Cinaciguat After a Single Intravenous Dose

作者:John T. Lettieri PhD ;Christian Scheerans PhD ;Martin Blunck PhD

来源:The Journal of Clinical Pharmacology. 2012 ;52(8):1240-1247.doi:10.1177/0091270011410567

出版社:John Wiley & Sons, Ltd.

全文购买

[期刊论文]

Novel aldo-keto reductase 1C3 inhibitor affects androgen metabolism but not ovarian function in healthy women: a phase 1 study

作者:Isabella Gashaw ;Stefanie Reif ;Herbert Wiesinger

来源:European Journal of Endocrinology. 2023 ;188(7):578-591.doi:10.1093/ejendo/lvad063

出版社:Bioscientifica

全文购买

[期刊论文]

Abstract CT276: Preliminary analysis of pharmacokinetic (PK) and target engagement biomarkers from a first in human phase 1 study of immunomodulatory aryl hydrocarbon receptor (AhR) inhibitor BAY2416964

作者:Kyriakos Papadopoulos ;Michael Cecchini ;Juanita S. Lopez

来源:Cancer Research. 2023 ;83(8_Supplement):CT276-CT276.doi:10.1158/1538-7445.AM2023-CT276

出版社:American Association for Cancer Research (AACR)

全文购买

[期刊论文]

Pharmacokinetics of the Soluble Guanylate Cyclase Activator Cinaciguat in Individuals With Hepatic Impairment

作者:Dr Reiner Frey MD ;Dr Christian Scheerans PhD ;Dr Martin Blunck PhD

来源:The Journal of Clinical Pharmacology. 2012 ;52(11):1714-1724.doi:10.1177/0091270011426143

出版社:John Wiley & Sons, Ltd.

全文购买

[期刊论文]

Quantitative Systems Pharmacology Approaches for Immuno‐Oncology: Adding Virtual Patients to the Development Paradigm

作者:Rolf Burghaus ;Christian Scheerans ;J?rg Lippert

来源:Clinical Pharmacology And Therapeutics. 2021 ;109(3):605-618.doi:10.1002/cpt.1987

出版社:John Wiley & Sons, Ltd.

全文购买